Revolutionizing Clinical Trials: Lindus Health Secures $25 Million in Funding for Accelerated Patient Treatment Innovation

Lindus Health is thrilled to announce a significant funding milestone, having raised $25 million to propel our mission of accelerating clinical trials and providing patients with access to innovative treatments sooner. As an anti-CRO, Lindus Health is redefining how clinical studies are conducted by providing a more efficient, reliable, and transparent process for life science pioneers. Our unique commercial model, based on fixed-priced quotes and milestone-based payments, ensures that both sponsors and patients reap the rewards of timely clinical research. With this new funding, we aim to further enhance our world-class clinical operations team and bolster our innovative software platform, which allows us unprecedented access to 30 million Electronic Health Records. With over 90 sponsors already benefiting from our services, our approach has demonstrated the ability to execute entire clinical studies across the US, UK, and Europe up to three times faster than traditional clinical research organizations (CROs). This investment will enable us to expand our capabilities, recruit more patients efficiently, and streamline all aspects of clinical trials—from design to monitoring and project management. At Lindus Health, we are committed to delivering on our promise of speed and reliability, ensuring that life-saving therapies reach those in need without delay. We believe that faster clinical trial execution will make a meaningful difference in the lives of patients and the broader healthcare landscape, and we're excited to take this next step in making that vision a reality.